Topic: Covaxin
This is why blood from newborn cattle is being used to develop Indian Covid vaccine
Blood serum from newborn cattle is a key ingredient in biological research, such as the development of vaccines, and is widely available for import.
Covaxin produced ‘robust’ immune response in monkeys, ICMR paper says
Data from the animal trials of Covaxin, India's first indigenous Covid vaccine candidate being developed by Bharat Biotech and ICMR, is yet to be peer-reviewed.
India holds the key for global access to Covid-19 vaccine
India has the potential to play a key role in overcoming vaccine nationalism because it is the major supplier of medicines to the global south.
Bharat Biotech wants to test administering Covid vaccine through skin instead of muscle
Intradermal vaccine delivery, if proven effective, could make Covaxin shots cheaper since they require a lesser amount of vaccine, which also means more people can get vaccinated.
Don’t expect Covaxin news on 15 August, says Bharat Biotech, phase 1 of ICMR trial still on
Twelve trial sites are testing the ICMR-Bharat Biotech-developed Covid vaccine candidate. Last month, ICMR spurred controversy by setting a 15 Aug-deadline for finishing trial.
Bharat Biotech — India’s Covid vaccine hope first shot to fame for $1 rotavirus vaccine
The $1 Rotavac may be its crowning glory but Bharat Biotech has a diverse repertoire that includes BioHib, India’s only indigenously developed influenza vaccine.
Delhi’s Dr Dangs chosen as central lab for Covaxin human trials, to check safety of vaccine
Dr Dangs Lab in South Delhi is already receiving samples samples from all 12 trial sites across the country for screening and safety testing.
Human trials of Bharat Biotech’s Covid vaccine Covaxin begin in Rohtak
Haryana Health Minister Anil Vij said the trials have begun at Rohtak's Post-Graduate Institute of Medical Sciences, and the first 3 subjects have 'tolerated' the vaccine well.
How Covid impacts education and the recipe for ICMR’s vaccine
The best cartoons of the day, chosen by the editors at ThePrint.
‘Taskmaster, skilled administrator, impulsive’ — ICMR’s Bhargava who wanted vaccine by 15 Aug
Dr Balram Bhargava’s letter expediting Covid vaccine trials was slammed, but current & ex-colleagues highlight both his ‘impetuosity’ & ‘impeccable integrity’.
How to prevent Navika Kumar from reading your private WhatsApp chats
Data security is a spectrum. Small things can help you be on the more secure side of the spectrum.
Harley-Davidson riding away reflects poorly on both US icon and Modi’s ‘Make in India’
Modi’s ambitious plans to ‘Make in India’ could have been helped by a symbolic gesture to hold on to Harley, a premium manufacturer with an outsize brand.
Defence
India, China working on Ladakh peace formula — alternate week patrolling, after disengagement
Patrolling in alternate weeks has been the established practice in the Northeast, and has worked well, barring the occasional face-off.
Suspect all, fix all? Is that the motto of our new ‘National Suspicion State’?
It’s not just Modi government or BJP, but even state governments, judiciary are getting caught in a ‘we suspect all’ mindset. Is India becoming a National Suspicion State?